Hyaluronic acid and intestinal inflammation

Current Opinion in Gastroenterology

Volumn 26, Issue 2, 2010, Pages 85-87

  Stenson, William F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE;

COLITIS; ENTERITIS; ILEITIS; INTESTINE INJURY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SHORT SURVEY; T LYMPHOCYTE ACTIVATION;

ANIMALS; COLITIS; ENTEROCOLITIS; FEMALE; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; ILEITIS; INFLAMMATION MEDIATORS; JEJUNAL DISEASES; MALE; MICE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 77149131249     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328334b417     Document Type: Short Survey

References (22)

1. Karamanos NK, Axelsson S, Vanky P, et al. Determination of hyaluronan and galactosaminoglycan disaccharides by high-performance capillary electrophoresis at the attomole level. Applications to analyses of tissue and cell culture proteoglycans. J Chromatogr A 1995; 696:295-305.
2. Tammi R, Saamanen A, Maibach H, Tammi M. Degradation of newly synthesized high molecular mass hyaluronan in epidermal and dermal compartments of human skin in organ culture. J Invest Dermatol 1991; 97:126-130.
3. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997; 242:27-33.
4. Stern R, Asar A, Sugahara K. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006; 85:699-715.
5. Itano N, Atsumi F, Sawai T, et al. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci USA 2002; 99:3609-3614.
6. Itano N, Sawai T, Atsumi F, et al. Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. J Biol Chem 2004; 279:18679-18687.
7. Stern R. Hyaluronidases in cancer biology. Semin Cancer Biol 2008; 18:275-280.
8. Lepperdinger G, Strobi B, Kreil G. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem 1998; 273:22466-22470.
9. Bourguignon LYW, Singleton PA, Diedrich F, et al. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem 2004; 279:26991-27007.
10. Frost GI, Csoka TB, Wong T. Stern: purification, cloning and expression of human plasma hyaluronidase. Biochem Biophys Res Commun 1997; 236: 10-15.
11. Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by toll-like receptors and hyaluronan. Nat Med 2005; 11:1173-1179.
12. Taylor K, Yamasaki K, Radek K, et al. Recognition of hayluronan released in sterile injury involves a unique receptor complex dependent on toll-like receptor 4, CD44, and MD-2. J Biol Chem 2007; 282:18265-18275.
13. De la Motte C, Hascall VC, Drazba J, et al. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid. Am J Pathol 2008; 163:121-133.
14. Kessler S, Rho H, West G, et al. Hyaluronan (HA) deposition precedes and promotes leukocyte recruitment in intestinal inflammation. CTS Journal 2008; 1:57-61.
15. Zheng L, Riehl T, Stenson WF. Regulation of colonic epithelial repair in mice by toll-like receptors and hyaluronic acid. Gastroenterology (in press).
16. De la Motte C, Migro J, Vasanji A, et al. Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines. Am J Pathol 2009; 174:2254-2264.
17. Brown SL, Riehl T, Walker M, et al. MyD88-dependent positioning of Ptgs2- expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest 2007; 117:258-269.
18. Fukata M, Chen A, Klepper A, et al. Cox-2 is regulated by toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 2006; 131:862-877.
19. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by TLRs is required for intestinal homeostasis. Cell 2004; 118:229-241.
20. Collins CB, Ho J, Wilson TE, et al. CD44 deficiency attenuates chronic murine ileitis. Gastroenterology 2008; 135:1993-2002.
21. Wittig B, Schwarzler C, Fohr N, et al. Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody. J Immunol 1998; 161:1069-1073.
22. Wittig BM, Johansson B, Zoller M, et al. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J Exp Med 2000; 191:2053-2063.